United States · FDA National Drug Code directory
BESREMi Pen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73536-511_801f0478-b00c-4e98-90c0-0a32201be6a2
- Product NDC
- 73536-511
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ROPEGINTERFERON ALFA-2B
- Labeler
- PharmaEssentia USA
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260625
- Source listing expiry
- 20271231
Source-listed ingredients
- ROPEGINTERFERON ALFA-2B — 500 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CARTRIDGE in 1 CARTON (73536-511-01) / .5 mL in 1 CARTRIDGE · 73536-511-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →